Our results show that NEURL1 was specifically upregulated, and the high expression predicted high RFS in LumB-subtype breast cancer (p < 0.05), which is consistent with the prognostic conclusion of all breast cancer. This evidence concerns the gene NEURL1 and breast cancer.